ArticleNoro psikiyatri arsivi2025
Plasma Oxytocin Levels in Body-Focused Repetitive Behavior Disorders and Their Relationship with Disease Severity, Attachment and Emotion Regulation.
Article in Noro psikiyatri arsivi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Oxytocin (OXT) is thought to play a role in processes such as social bonding, empathy, and emotional regulation, as well as in the pathophysiology of repetitive/grooming behaviors. The aim of this study is to compare plasma OXT levels in individuals with body-focused repetitive behavior disorder (BFRBD) to those in a healthy control group, and to examine the relationship of OXT with disease severity, emotional regulation, and attachment styles. Methods: This study included 35 patients aged 18-45 diagnosed with BFRBD who visited the psychiatry outpatient clinic, and 35 healthy controls with matched age, gender, and partner-status. Participants were assessed using the Beck depression inventory (BDI), difficulties in emotion regulation scale (DERS-16), experiences in close relationships inventory-II (ECR-II), and Hendrick relationship satisfaction scale (HRSS), and plasma OXT levels were measured. Results: Oxytocin levels in patients with BFRBD were found to be significantly lower than in healthy controls (p<0.001). Patients had higher scores for insecure attachment and difficulties in emotional regulation (p<0.01). Additionally, a negative correlation was observed between the severity of skin-picking behavior and OXT levels (p=0.033). Conclusion: The insufficiency of OXT levels in BFRBD patients and its association with disease severity suggest that OXT may play a role in the psychopathology of BFRBD. Further research is needed to explore the role of OXT and its therapeutic potential in this disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.